Daré Bioscience announces peer-reviewed Phase 1 sildenafil cream study
Daré Bioscience said a peer-reviewed Phase 1 study in men reported substantially lower systemic exposure for its sildenafil cream versus oral sildenafil.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.